Skip to main content
. 2002 Mar;40(3):926–932. doi: 10.1128/JCM.40.3.926-932.2002

TABLE 3.

Detection of HPV-16 neutralizing antibodies in human sera

Group Anti-VLP result No. with neutralizing antibodies to HPV-16/total (%)
General population 0/45 (0.0)
    Children (6-12 months old) Negative 0/20 (0.0)
    HPV DNA-negative women Negative 0/15 (0.0)
Positive 0/10 (0.0)
Cervical cancer patients 12/31 (38.7)
    HPV-16 DNA-positive     women Negative 0/8 (0.0)
Positive 11/17 (64.7)
    HPV DNA-negative women Negative 0/5 (0.0)
Positive 1/1 (100)